MedTrace Logo

PTEN-AKT-FOXO3 Gene Expression Relation With Low-ovarian Reserve in Endometriomas

NCT04058912 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-08-16

No results posted yet for this study

Summary

In this study, we aimed to investigate the relationship between PTEN-AKT-FOXO3 gene expression and decrease in ovarian reserve in the presence of endometrioma and other benign ovarian pathologies.

Conditions

  • Ovarian Reserve, Endometrioma, PTEN-AKT-FOXO3 Gene Expression

Interventions

GENETIC

PTEN-AKT-FOXO3 Gene Expression

In the patient and patient control groups, 0.5 mm tissue strip will be removed for pathology from the cyst wall removed during surgery. and tissue samples will be stored in phosphate buffered saline at -80 C and PTEN-AKT-FOXO3 gene expression level will be evaluated by RT-PCR analysis.

Sponsors & Collaborators

  • Uludag University

    lead OTHER

Principal Investigators

  • GURKAN UNCU, Prof · ULUDAG UNIVERSITY HOSPITAL BURSA TURKEY

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-27
Primary Completion
2020-05-27
Completion
2020-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04058912 on ClinicalTrials.gov